BIP
BMY icon

Bouvel Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bouvel Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80
Closed -$5K – 67
2020
Q4 		$5K Buy
+80
New +$4.92K ﹤0.01% 72

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bouvel Investment Partners's BMY Position: Q1 2021 in Review

Bouvel Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 80 shares — an estimated $5K sold.

Bouvel Investment Partners first reported a position in BMY in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Bouvel Investment Partners reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • Bouvel Investment Partners sold 80 Bristol-Myers Squibb shares in Q1 2021, an estimated $5K.
  • Bouvel Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 1 quarter.
  • Bouvel Investment Partners's Bristol-Myers Squibb position peaked at $5K in Q4 2020.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Bouvel Investment Partners's 13F filing for Q1 2021, filed 16 Apr 2021.